Prior to prescribing the ABILIFY MYCITE Maintenance Kit ensure the patient has access to the appropriate components of the patch [seeHOW SUPPLIED/Storage And Handling]. Although most ingestions will be detected within 30 minutes, it may take up to two hours for the app and portal to detect the...
Abilify Mycite®: Adults—At first, 15 milligrams (mg) once a day. When it is given with lithium or valproate, the starting dose is 10 to 15 mg once a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 30 mg per day. ...
Stop using Abilify and call your doctor at once if you have the following symptoms: fever with stiff muscles and rapid heart rate; uncontrolled muscle movements; symptoms that come on suddenly such as numbness or weakness, severe headache, and problems with vision, speech, or balance. ...
Abilify MyCite Maintenance Kit oral with sensor drug information Abilify MyCite Starter Kit oral with sensor Abilify Mycite (Advanced Reading) Other brands Aristada, Abilify Asimtufii, Aristada Initio, Abilify Discmelt Professional resources Abilify Mycite prescribing information Aripiprazole (AHFS Monograph...
Abilify MyCite Maintenance Kit oral with sensor Related treatment guides Bipolar Disorder Autism Depression Agitated StateFurther information Abilify side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your pe...
The oral tablet formulation Abilify MyCite (aripiprazole) is embedded with the ingestible Proteus sensor that allows patients, and, if given access, doctors and caregivers, to track ingestion of the Abilify medication on a smartphone or web-based portal. The system sends a message from the pill...
Brand names:Abilify, Abilify Discmelt,Abilify Mycite Drug class:Atypical antipsychotics Medically reviewedby Drugs.com. Last updated on Nov 15, 2024. The Abilify Discmelt brand name has beendiscontinuedin the U.S. If generic versions of this product have been approved by the FDA, there may be...